We are live on ! Find out more
TA

Tamarack Advisers Portfolio holdings

AUM $2.12M
1-Year Est. Return 58.09%
This Fund
S&P 500
This Quarter Est. Return
-1.42%
1 Year Est. Return
-58.09%
3 Year Est. Return
-46.51%
5 Year Est. Return
+44.44%
10 Year Est. Return
–
AUM
$384M
AUM Growth
+$54.9M
Cap. Flow
+$65.4M
Cap. Flow %
17.05%
Top 10 Hldgs %
73.72%
Holding
34
New
13
Increased
12
Reduced
3
Closed
3

Top Buys

Rank Stock Value
1
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$12.5M
2
ZBH icon
Zimmer Biomet
ZBH
+$9.31M
3
ITGR icon
Integer Holdings
ITGR
+$9.1M
4
HMSY
HMS Holdings Corp.
HMSY
+$8.13M
5
ICUI icon
ICU Medical
ICUI
+$6.97M

Top Sells

Rank Stock Value
1
HAE icon
Haemonetics
HAE
+$12.1M
2
NVCR icon
NovoCure
NVCR
+$9.64M
3
SRCL
Stericycle Inc
SRCL
+$5.82M
4
MDT icon
Medtronic
MDT
+$2.09M
5
DGX icon
Quest Diagnostics
DGX
+$1.43M

Sector Composition

Rank Sector Weight
1 Healthcare 85.81%
2 Industrials 6.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
26
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$781B
$850K 0.22%
5,000
+1,000
+25% +$295K
XLV icon
27
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$42.2B
$540K 0.14%
+5,000
New +$457K
ABT icon
28
PUT
Abbott
ABT
$182B
$233K 0.06%
+900
New +$76.5K
MDRX
29
CALL
DELISTED
Veradigm Inc. Common Stock
MDRX
$208K 0.05%
+2,000
New +$20.5K
MEDP icon
30
PUT
Medpace
MEDP
$16.5B
$116K 0.03%
+350
New +$26.4K
OEF icon
31
CALL
iShares S&P 100 ETF
OEF
$19.8B
$110K 0.03%
+10,000
New +$1.31M
AMGN icon
32
PUT
Amgen
AMGN
$203B
– –
-250
Closed -$11K
HAE icon
33
Haemonetics
HAE
$3.63B
– –
-100,000
Closed -$12.1M
NVCR icon
34
NovoCure
NVCR
$1.97B
– –
-150,000
Closed -$9.64M
1
2

Similar funds

SCM
SevenOneSeven Capital Management Lancaster, Pennsylvania $2.17M AUM 8.67% 1-Year Est. Return
LBC
Lawrence B. Cohen $2.06M AUM 34.47% 1-Year Est. Return
ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
LCMP
Linse Capital Management PR San Juan, Puerto Rico $2.31M AUM
GIP
General Industrial Partners London, United Kingdom $2.57M AUM
STC
Sarah T. Connolly $1.11M AUM 24.13% 1-Year Est. Return
GC
Gilfoyle & Co San Francisco, California $671K AUM
DU
Delphia (USA) Toronto, Ontario, Canada $445K AUM 28.82% 1-Year Est. Return

Tamarack Advisers's Q3 2019 Portfolio in Review

As of Q3 2019, Tamarack Advisers held 34 positions worth $384M, up 17% from $329M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Tamarack Advisers deployed $65.4M of net new capital in Q3 2019, opening 13 new positions and adding to 12 existing holdings. Its largest new stake was Integer Holdings: 115,000 shares worth $8.69M.

By sector, the portfolio is most concentrated in Healthcare at 86% of assets, down from 89% a quarter earlier, followed by Industrials.

On the sell side, the largest reduction was Stericycle Inc, an estimated $5.82M trimmed.

  • Tamarack Advisers's largest Q3 2019 buy was Integer Holdings: 115,000 shares worth $8.69M.
  • Tamarack Advisers added most to Portola Pharmaceuticals, Inc. in Q3 2019, an estimated $12.5M increase.
  • Tamarack Advisers's biggest Q3 2019 reduction was Stericycle Inc, cutting an estimated $5.82M.
  • Tamarack Advisers fully exited Haemonetics in Q3 2019, selling an estimated $12.1M.
  • Tamarack Advisers's ten largest holdings make up 74% of its $384M portfolio in Q3 2019.
  • Tamarack Advisers opened 13 new positions and closed 3 in Q3 2019.
  • Tamarack Advisers's portfolio value rose 17% quarter-over-quarter to $384M.

Based on Tamarack Advisers's 13F filing for Q3 2019, filed 5 Nov 2019.